Hydroxyzine Pamoate Capsule
Product Images NDC 51655-847

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 51655-847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 847 20 Rev A 04 23)

Label for hydroxyzine pamoate capsules, USP 25 mg, containing 20 capsules, labeled as Rx only. Instructions include dosage information to refer to the package insert and storage at 20°-25°C. The label also warns to keep out of reach of children and store in the original container. The product is repackaged by Northwind Pharmaceuticals.*

FDA Label Image

Chemical Structure (Hypam 01)

Chemical structure diagram showing the molecular formula of hydroxyzine pamoate, the active ingredient in the medication hydroxyzine pamoate 25 mg oral capsules by Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.